IACR Newsflash

IARC Fellowships

Training opportunites at IARC: Applications are now open for 2019 awards

Details are available at: IARC Fellowship Programme Page. Deadline for applications is on 30 November 2018.  Successful applicants will be notified by the end of May 2019.

Email IARC Education and Training Group:  This email address is being protected from spambots. You need JavaScript enabled to view it.


Draft ICD-O-3.2

The IARC/WHO ICD-O Committee1 has updated the currently recommended ICD-O-3.1 classification (pdf available from: ICD-O, with new morphology codes and terms from the 4th series of WHO Classification of Tumours (Blue Books). The new version, ICD-O-3.2, will be recommended for use from 2019. The IACR Working Group on ICD-O Updates2 has compiled a listing of additions, changes and revisions between ICD-O-3.1 and ICD-O-3.2 as a reference material for cancer registries.

These documents are available here and will remain open for feedback until 1 November 2018. If you have any comments, please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

After the consultation period, the final version will be locked and ICD-O-3.2 pdf generated.

1 Ian Cree, Robert Jakob, Brian Rous, Ariana Znaor

2 Atul Budukh, Jacques Ferlay, Keri Green, Tomohiro Matsuda, Brian Rous, Ariana Znaor

8th Edition TNM Classification Survey

The recently introduced UICC/AJCC 8th edition TNM classification includes numerous changes in head and neck cancer (HNC) staging. Some of the initial feedback suggests potential concerns and challenges in the adoption and implementation of the new classification for clinical care, research, and cancer registration.

In order to better appreciate issues relating to adoption of the new HNC staging classification, and to evaluate this experience from the user perspective, international HNC staging users and stakeholders are requested to participate in a survey. The survey population has been defined by identifying corresponding authors from recent publications (2017-2018) using a comprehensive Medline search of 3000 articles related to the clinical management of HNC.

The aim of the survey is to improve adoption of the current TNM edition, and guide the formulation and implementation of future updates. The Committee requests cancer registrars to participate in the 10-15 minute survey and would appreciate the valuable input by 30th October 2018.

 Access the TNM8 HNC Staging Survey

Best wishes,
Brian O’Sullivan (UICC) and William Lydiatt (AJCC)
Head and Neck Staging Committee Leaders

Cancer in Sub-Saharan Africa

In time with the African Cancer Registry Network (AFCRN)'s 2018 Annual Review Meeting held on Oct 8-10 in Entebbe, Uganda, IARC and AFCRN published Cancer in Sub-Saharan Africa.

IARC Publication 167, 2018, includes the latest cancer data for the region. The Cancer in Sub-Saharan Africa volume brings together population-based cancer incidence data from 25 cancer registries in 20 sub-Saharan African countries that are part of the African Cancer Registry Network. The compiled data in this volume, presented and commented upon by covered population and by anatomical site, are of tremendous value to the assessment of the pattern and evolution of cancer in Africa, as a means of elucidating, confirming, and evaluating causes of the disease.

Updated IARC/IACR crgTools

A new version of the IARC/IACR edit checks is available, the IARCcrgTools package includes:
• An updated version of the Multiple primary check program which takes into consideration the new ICD-O-3 1st revision morphological codes;
• The ICD-O-3 1st revision to ICD-10 (2010 edition) conversion program used in the preparation of CI5 Vol. XI

Click on here to download: Download the latest version of IARCcrgTools 

For assistance/ queries, please contact Mr. Jacques Ferlay at This email address is being protected from spambots. You need JavaScript enabled to view it.

  •  Start 
  •  Prev 
  •  Next 
  •  End 

Page 1 of 3

Our partners

120507 01b LOGO X3





This website was developed and is hosted at the International Agency for Research on Cancer (IARC)
Go to top